Atlas Trials

Study of Anlotinib Combined With Pemetrexed in Patients With Advanced Nonsquamous NSCLC

Clinical trial NCT03778138 · UNKNOWN

Trial details

NCT number
NCT03778138
Sponsor
Henan Provincial People's Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Non-squamous Cell Non-Small Cell Lung Cancer
Start date
2019-01-01
Primary completion
2019-12-31
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.